ResearcherKyushu UniversityActive in the last 2 years
Shingo Baba
Matched on ORCID iD 0000-0003-4338-3497; OpenAlex author ID A5081253979, A5144264299. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 34
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maximum standardized uptake value 4.0 thresh… Co-author DOI 10.1016/j.surg.2026.110503↗
- Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. Co-author DOI 10.1007/s11605-023-05591-2↗
- Prediction of pathological response to preoperative chemotherapy for pancreatic ductal adenocarcinoma using 2-[18F]-fluoro-2-deoxy-d-glucose positron-emission … Last author DOI 10.1016/j.crad.2022.03.001↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kousei Ishigami · 3 shared papers, 2022–2026 · strength 0.50
- Paper International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maxi… DOI 10.1016/j.surg.2026.110503↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Paper Prediction of pathological response to preoperative chemotherapy for pancreatic ductal adenocarcinoma using 2-[18F]-flu… DOI 10.1016/j.crad.2022.03.001↗
- Naoki Ikenaga · 2 shared papers, 2023–2026 · strength 0.35
- Paper International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maxi… DOI 10.1016/j.surg.2026.110503↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Yoshinao Oda · 2 shared papers, 2022–2023 · strength 0.31
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Paper Prediction of pathological response to preoperative chemotherapy for pancreatic ductal adenocarcinoma using 2-[18F]-flu… DOI 10.1016/j.crad.2022.03.001↗
- Kohei Nakata · 2 shared papers, 2022–2023 · strength 0.31
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Paper Prediction of pathological response to preoperative chemotherapy for pancreatic ductal adenocarcinoma using 2-[18F]-flu… DOI 10.1016/j.crad.2022.03.001↗
- Isamu Makino · 1 shared paper, 2026 · strength 0.19
- Atsushi Tomioka · 1 shared paper, 2026 · strength 0.19
- Teiichi Sugiura · 1 shared paper, 2026 · strength 0.19
- Shintaro Yagi · 1 shared paper, 2026 · strength 0.19
- Yoo‐Seok Yoon · 1 shared paper, 2026 · strength 0.19
- Tetsuya Idichi · 1 shared paper, 2026 · strength 0.19
- Hongbeom Kim · 1 shared paper, 2026 · strength 0.19
- Hyung Il Seo · 1 shared paper, 2026 · strength 0.19
- Shigeru Marubashi · 1 shared paper, 2026 · strength 0.19
- Naru Kim · 1 shared paper, 2026 · strength 0.19
- Minoru Oshima · 1 shared paper, 2026 · strength 0.19
- Munseok Choi · 1 shared paper, 2026 · strength 0.19
- Masayuki Tanaka · 1 shared paper, 2026 · strength 0.19
- Katsuhisa Ohgi · 1 shared paper, 2026 · strength 0.19
- Yoon Soo Chae · 1 shared paper, 2026 · strength 0.19
- Etsuro Hatano · 1 shared paper, 2026 · strength 0.19
- Satoshi Hirano · 1 shared paper, 2026 · strength 0.19
- Tsutomu Fujii · 1 shared paper, 2026 · strength 0.19
- Wooil Kwon · 1 shared paper, 2026 · strength 0.19
- Keiichi Okano · 1 shared paper, 2026 · strength 0.19
- Masayuki Ohtsuka · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.